Tech Company Financing Transactions
Neurona Therapeutics Funding Round
On 12/2/2015, Neurona Therapeutics raised $23.5 million in Series A funding from The Column Group and private investors.
Transaction Overview
Company Name
Announced On
12/2/2015
Transaction Type
Venture Equity
Amount
$23,500,000
Round
Series A
Investors
The Column Group (Lead Investor) (Timothy Kutzkey)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
170 Harbor Way
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Timothy Kutzkey
Chief Executive Officer
Cory Nicholas
VP - Bus. Development
Michael Greenberg
VP - Bus. Development
Catherine Priest
VP - Finance
James Tanaka
VP - Human Resources
Celinda Moore
VP - Manufacturing
Gautam Banik
VP - Operations
Alessandro Bulfone
VP - Regulatory Affairs
Estela Alvarez
VP - Regulatory Affairs
Paurene Duramad
VP - Regulatory Affairs
Sergei Shevchuk
Browse more venture capital transactions:
Prev: 12/2/2015: Burpple venture capital transaction
Next: 12/2/2015: GCT Semiconductor venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs